Wuhan Hvsen Biotechnology Co.,Ltd. (SHE:300871)
China · Delayed Price · Currency is CNY 27.30
-0.62 (-2.22%)
Apr 21, 2026, 3:04 PM CST
Wuhan Hvsen Biotechnology Market Cap
Wuhan Hvsen Biotechnology has a market cap or net worth of 5.51 billion as of April 21, 2026. Its market cap has increased by 167.28% in one year.
Market Cap
5.51B
Enterprise Value
5.28B
Revenue
1.68B
Ranking
n/a
PE Ratio
21.13
Stock Price
27.30
Market Cap Chart
Since August 24, 2020, Wuhan Hvsen Biotechnology's market cap has decreased from 6.83B to 5.51B, a decrease of -19.40%. That is a compound annual growth rate of -3.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 20, 2026 | 5.63B | 34.82% |
| Dec 31, 2025 | 4.18B | 151.73% |
| Dec 31, 2024 | 1.66B | -29.78% |
| Dec 29, 2023 | 2.36B | -29.56% |
| Dec 30, 2022 | 3.36B | -29.11% |
| Dec 31, 2021 | 4.73B | 7.30% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Aug 24, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lifecome Biochemistry | 6.24B |
| Shouyao Holdings (Beijing) Co., LTD. | 6.24B |
| Kexing Biopharm | 6.17B |
| Shenzhen Weiguang Biological Products | 6.13B |
| Beijing Scitop Bio-tech | 6.12B |
| Innovita Biological Technology | 6.04B |
| Novogene | 5.86B |
| Beijing Konruns Pharmaceutical | 5.80B |